Med. praxi. 2020;17(5):290-298 [Prakt. lékáren. 2020; 16(4): 233-242]

Acute respiratory infection - symptomatic self-medication in adults

PharmDr. Bc. Hana Kotolová, Ph.D., PharmDr. Tomáš Hammer
Ústav farmakologie a toxikologie, Farmaceutická fakulta, Masarykova univerzita, Brno

Addressing respiratory infections is a common reason to visit a pharmacy. Although the cause of problems can be diverse in terms of inducing agents, many of them can be addressed through self-medication. In 2020, COVID ‑ 19, which is caused by the coronavirus SARS-CoV-2, is a very current topic. Symptomatic treatment is indicated as monotherapy for respiratory infections of primarily viral etiology, otherwise it is administered as an adjunct to causal treatment. We currently have a range of over-the-counter drugs from various pharmacotherapeutic groups. In addition to drugs, phytopharmaceuticals can also be used. An essential part of the treatment is bed rest, plenty of fluids and a light diet supplemented with vitamins.

Keywords: respiratory infections, self‑medication.

Published: January 5, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kotolová H, Hammer T. Acute respiratory infection - symptomatic self-medication in adults. Med. praxi. 2020;17(5):290-298.

Download citation

References

  1. Sexton DJ, et al. The common cold in adults: Treatment and prevention. Official reprint from UpToDate® 2016.
  2. Formánek M, a kol. Terapie nemocí z nachlazení, Med. praxi 2016; 13(1): 20-24.
  3. Kotolová H. Nachlazení - Doporučený postup, Česká lékárnická komora, verze RR 2018.
  4. Beran J. Chřipka - očkování je základem prevence. Klin. Farmakol Farm 2010; 24(1): 25-28.
  5. Petráš M. Očkování proti chřipce. Doporučený postup, Česká lékárnická komora 2014.
  6. Kolek V, a kol. Kapesní průvodce ambulantní léčbou respiračních infekcí. Maxdorf‑Jessenius 2016.
  7. Slíva J. Symptomatická léčba chřipky. Prakt. lékáren. 2012; 8(1): 34-37.
  8. World Health Organization, et al. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization, 2020. Go to original source...
  9. Havlík J. Chřipková onemocnění v dětském věku. Pediatr.praxi 2001; 1: 10-12.
  10. Coronavirus Symptoms. World Health Organization [online]. WHO, 2020. Dostupné z: https://www.who.int/health‑topics/coronavirus#tab=tab_3).
  11. Kim SY, et. al. Non‑steroidal anti‑inflammatory drugs for the common cold. Cochrane Database of Systematic Reviews 2015; 9: CD006362. Go to original source... Go to PubMed...
  12. Horečka u dětí, Farmakoterapeutické informace, 9/2010.
  13. AISLP, verze 2020.3 s.
  14. Kompendium lékových interakcí, verze 10.2016.
  15. Suchopár J, et al. Remedia compendium, Panax 2009.
  16. Optimální dávkování paracetamolu a možnosti zvýšení jeho účinnosti, SUKL - Farmakoterapeutické informace, 2-3.2015.
  17. Vondra V. Kašel: klinický přístup, vzdělávací kurz. 2019. [online]. Dostupné z: proLekarniky.cz.
  18. Kopřiva K. Chronický kašel. Maxdorf Jessenius 2015.
  19. Juřica J. Moderní terapie kašle. Prakt. lékáren. 2013; 9(6): 219-224.
  20. Hendrychová T, a kol. Poradenství v lékárně při samoléčení kašle. Prakt. lékáren. 2012; 8(5): 229-235.
  21. Farmakoterapeutické informace. 6/2018. ISSN 1211-0647.
  22. Juřica J. Farmakoterapie kašle ve zkratce. Prakt. Lékáren. 2017; 13(1): 306-311. Go to original source...
  23. Kotolová H. Symptomatická léčba chřipky a nachlazení, Prakt. Lékáren. 2017; 13(1): 22-29. Go to original source...
  24. Dicpinigaitis PV, Morice AH, Birring SS, McGarvey L, Smith JA, Canning BJ, Page CP. Antitussive Drugs - Past, Present, and Future. Pharmacological Reviews 2014; 66(2): 468. Go to original source... Go to PubMed...
  25. Zanasi A, Lanata L, Fontana G, Saibene F, Dicpinigaitis P, De Blasio F. Levodropropizine for treating cough in adult and children: a meta‑analysis of published studies. Multidisciplinary Respiratory Medicine. 2015; 10(1): 19. Go to original source... Go to PubMed...
  26. Dal Negro RW, et al. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases. Pulm Pharm Ther 2018; 53: 80-85. Go to original source... Go to PubMed...
  27. Cazzola M, Rogliani P, Calzetta L, et al. Impact of mucolytic agents on COPD exacerbations: a pair‑wise and network meta‑analysis. COPD 2017; 14(5): 552-563.
  28. Polonikov A. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infect, DiS. 2020 Jul 10; 6(7): 1558-1562. Go to original source... Go to PubMed...
  29. Santus P, Tursi F, Croce G, Di Simone C, Frassanito F, Gaboardi P, Airoldi A, Pecis M, Negretto G, Radovanovic D. Changes in quality of life and dyspnoea after hospitalization in COVID-19 patients discharged at home. Multidis Res Med 2020, 15: 713. Go to original source... Go to PubMed...
  30. Meo SA, Al‑Asiri SA, Mahesar AL, Ansari MJ. Role of honey in modern medicine. Saudi J Biol Sci. 2017; 24(5): 975-978. Go to original source... Go to PubMed...
  31. Raessi M. A. Honey plus coffee versus systemic steroid in the treatment of persistent post‑infectious cough: a randomised controlled trial. Primary care of Respiratory Journal 2013; 22: 325-333. Go to original source... Go to PubMed...
  32. Malesker MA, Callahan‑Lyon P, Ireland B, Irwin RS; CHEST Expert Cough Panel. Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report. Chest. 2017; 152(5): 1021-1037. Go to original source... Go to PubMed...
  33. Kotolová H. Možnosti ovlivnění akutního kašle v rámci respiračních infekcí u dětí. Pediatr. Praxi. 2020; 21(5): 315-319. Go to original source...
  34. Stead W. Patient education: Sore throat in adults (Beyond the Basics), Databáze UpToDate, Jul 03, 2019.
  35. Kotolová H, Kollár P. Bolest v krku, Doporučený postup České lékárnické komory, verze RR 2018.
  36. Rottenberg J, Kostřica R. Bolesti v krku. Doporučené postupy ČLS JEP.
  37. Medrano M, Carrillo‑Cruz E, Montero I, Perez‑Simon JA. Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications. Int J Mol Sci. 2018; 19(9): 2663. Published 2018 Sep 8. doi:10.3390/ijms19092663 Go to original source... Go to PubMed...
  38. Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta‑analysis. Health Technol Assess. 2019; 23(2): 1-44. doi:10.3310/hta23020 Go to original source... Go to PubMed...
  39. Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017; 9(11): 1211. Published 2017 Nov 3. doi: 10.3390/nu9111211. Go to original source... Go to PubMed...
  40. Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko S, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, Aaseth J, et al. Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review). Int J Mol Med 2020; 46: 17-26. Go to original source... Go to PubMed...
  41. Maggini S, Pierre A, Calder PC. Immune Function and Micronutrient Requirements Change over the Life Course. Nutrients. 2018; 10(10): 1531. Published 2018 Oct 17. doi: 10.3390/nu10101531. Go to original source... Go to PubMed...
  42. Golnoosh T, et al. "Anti‑influenza activity of elderberry (Sambucus nigra)." Journal of functional foods 2019; 54: 353-360. Go to original source...
  43. Tůmová L. Lékořice - terapeutické účinky a možné interakce. Prakt. lékáren. 2011; 7(6): 286-287.Další literatura u autorky a na www.medicinapropraxi.cz
  44. Al‑Hariri M. Immune's‑boosting agent: Immunomodulation potentials of propolis. Journal of family & community medicine, 2019; 26(1): 57. Go to original source... Go to PubMed...
  45. Arreola R, et al. Immunomodulation and anti‑inflammatory effects of garlic compounds. Journal of immunology research, 2015; 2015. Go to original source... Go to PubMed...
  46. Yan, Fang Polk DB. Probiotics and immune health. Current opinion in gastroenterology, 2011; 27 (6): 496. Go to original source... Go to PubMed...
  47. Hudson J, Vimalanathan, Selvarani. Echinacea-A source of potent antivirals for respiratory virus infections. Pharmaceuticals, 2011; 4(7): 1019-1031. Go to original source...
  48. Ruprich J. Připravte nespecificky tělo na možné onemocnění koronaviry COVID-19: dobré tělesné kondici pomohou i omega-3 a vitamin D. CZVP SZÚ, 18. 3. 2020, doplněná a upravená verze 30. 3. 2020.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.